Literature DB >> 19948994

Science of self-preservation: how melanocortin action in the brain modulates body weight, blood pressure, and ischemic damage.

Marcus P Corander1, Matthew Fenech, Anthony P Coll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19948994      PMCID： PMC2880450          DOI： 10.1161/CIRCULATIONAHA.109.854612

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  69 in total

1.  Marshaling the Anti-Inflammatory Influence of the Neuroimmunomodulator alpha-MSH.

Authors:  J. M. Lipton; A. Catania; T. Ichiyama
Journal:  News Physiol Sci       Date:  2000-08

2.  Protective effect of melanocortin peptides in rat myocardial ischemia.

Authors:  C Bazzani; S Guarini; A R Botticelli; D Zaffe; A Tomasi; A Bini; M M Cainazzo; G Ferrazza; C Mioni; A Bertolini
Journal:  J Pharmacol Exp Ther       Date:  2001-06       Impact factor: 4.030

3.  Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone.

Authors:  W FERRARI
Journal:  Nature       Date:  1958-03-29       Impact factor: 49.962

4.  Leptin-induced increase in sympathetic nervous and cardiovascular tone is mediated by proopiomelanocortin (POMC) products.

Authors:  J C Dunbar; H Lu
Journal:  Brain Res Bull       Date:  1999-10       Impact factor: 4.077

5.  Evidence that melanocortin 4 receptor mediates hemorrhagic shock reversal caused by melanocortin peptides.

Authors:  S Guarini; C Bazzani; M M Cainazzo; C Mioni; G Ferrazza; A V Vergoni; H B Schiöth; J E Wikberg; A Bertolini
Journal:  J Pharmacol Exp Ther       Date:  1999-12       Impact factor: 4.030

6.  Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24).

Authors:  G Noera; M Lamarra; S Guarini; A Bertolini
Journal:  Lancet       Date:  2001-08-11       Impact factor: 79.321

7.  Proopiomelanocortin (POMC) products in the central regulation of sympathetic and cardiovascular dynamics: studies on melanocortin and opioid interactions.

Authors:  J C Dunbar; H Lu
Journal:  Peptides       Date:  2000-02       Impact factor: 3.750

8.  Incidence and precursors of hypertension in young adults: the Framingham Offspring Study.

Authors:  R J Garrison; W B Kannel; J Stokes; W P Castelli
Journal:  Prev Med       Date:  1987-03       Impact factor: 4.018

Review 9.  Proopiomelanocortin and energy balance: insights from human and murine genetics.

Authors:  Anthony P Coll; I Sadaf Farooqi; Benjamin G Challis; Giles S H Yeo; Stephen O'Rahilly
Journal:  J Clin Endocrinol Metab       Date:  2004-06       Impact factor: 5.958

10.  The appearance of proopiomelanocortin early in vertebrate evolution: cloning and sequencing of POMC from a Lamprey pituitary cDNA library.

Authors:  J A Heinig; F W Keeley; P Robson; S A Sower; J H Youson
Journal:  Gen Comp Endocrinol       Date:  1995-08       Impact factor: 2.822
View more
  10 in total

1.  Melanocortins protect against multiple organ dysfunction syndrome in mice.

Authors:  Alessandra Bitto; Francesca Polito; Domenica Altavilla; Natasha Irrera; Daniela Giuliani; Alessandra Ottani; Letteria Minutoli; Luca Spaccapelo; Maria Galantucci; Renzo Lodi; Giuseppe Guzzo; Salvatore Guarini; Francesco Squadrito
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

2.  Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.

Authors:  Natalie M Barkey; Narges K Tafreshi; Jatinder S Josan; Channa R De Silva; Kevin N Sill; Victor J Hruby; Robert J Gillies; David L Morse; Josef Vagner
Journal:  J Med Chem       Date:  2011-11-10       Impact factor: 7.446

Review 3.  Obesity-induced hypertension: role of sympathetic nervous system, leptin, and melanocortins.

Authors:  John E Hall; Alexandre A da Silva; Jussara M do Carmo; John Dubinion; Shereen Hamza; Shankar Munusamy; Grant Smith; David E Stec
Journal:  J Biol Chem       Date:  2010-03-26       Impact factor: 5.157

Review 4.  Role of the brain melanocortins in blood pressure regulation.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E Perez de Lara; John E Hall
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-06       Impact factor: 5.187

5.  Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway.

Authors:  Letteria Minutoli; Alessandra Bitto; Francesco Squadrito; Natasha Irrera; Mariagrazia Rinaldi; Piero Antonio Nicotina; Salvatore Arena; Carlo Magno; Herbert Marini; Luca Spaccapelo; Alessandra Ottani; Daniela Giuliani; Carmelo Romeo; Salvatore Guarini; Pietro Antonuccio; Domenica Altavilla
Journal:  Endocrinology       Date:  2011-08-09       Impact factor: 4.736

Review 6.  The brain melanocortin system, sympathetic control, and obesity hypertension.

Authors:  Alexandre A da Silva; Jussara M do Carmo; Zhen Wang; John E Hall
Journal:  Physiology (Bethesda)       Date:  2014-05

7.  Effect of selective expression of dominant-negative PPARγ in pro-opiomelanocortin neurons on the control of energy balance.

Authors:  Madeliene Stump; Deng-Fu Guo; Ko-Ting Lu; Masashi Mukohda; Xuebo Liu; Kamal Rahmouni; Curt D Sigmund
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

8.  Contribution of regional brain melanocortin receptor subtypes to elevated activity energy expenditure in lean, active rats.

Authors:  C Shukla; L G Koch; S L Britton; M Cai; V J Hruby; M Bednarek; C M Novak
Journal:  Neuroscience       Date:  2015-09-25       Impact factor: 3.590

9.  Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight.

Authors:  Mirian Bassi; Humberto Giusti; Cristiane Mota Leite; Janete A Anselmo-Franci; Jussara M do Carmo; Alexandre A da Silva; John E Hall; Eduardo Colombari; Mogens L Glass
Journal:  Pflugers Arch       Date:  2012-05-15       Impact factor: 3.657

10.  α-Melanocyte-Stimulating Hormone Attenuates Neovascularization by Inducing Nitric Oxide Deficiency via MC-Rs/PKA/NF-κB Signaling.

Authors:  Wen-Tsan Weng; Chieh-Shan Wu; Feng-Sheng Wang; Chang-Yi Wu; Yi-Ling Ma; Hoi-Hung Chan; Den-Chiung Wu; Jian-Ching Wu; Tian-Huei Chu; Shih-Chung Huang; Ming-Hong Tai
Journal:  Int J Mol Sci       Date:  2018-11-30       Impact factor: 5.923
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.